- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07382596
Cervikalt plexus hydrodisseksjon med D5W versus NS for behandlingsresistent PTSD
Cervical Plexus Hydrodissection med D5W versus NS for behandlingsresistent PTSD
PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with an injection control of normal saline (NS)
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
PTSD is a well-recognized debilitating mental health condition associated with previous trauma exposure. It is part of the DSM-5 Trauma and Stressor related disorders category. Treatments for PTSD normally involve a multi-disciplinary approach. First-line treatments include psychotherapy and serotonergic reuptake inhibitors. Many patients fail pharmacotherapy and psychotherapy. Unilateral stellate ganglion block performed favorably for treatment of PTSD in a recent RCT, based upon an expectation that the cervical sympathetic system is neuropathically upregulated in PTSD. However, inclusion of lidocaine requires the presence of an emergency response team due to the potential for inadvertent intravascular injection with generalized seizures or hypotension, and inadvertent laryngeal or phrenic nerve block. Perineural injection of peripheral nerves, plexi, or sympathetic ganglia with dextrose 5% in water (D5W), has performed well empirically in the treatment of post-traumatic stress disorder. No lidocaine is utilized, which allows for avoidance of lidocaine toxicity risk, or any risk of nerve block. Because of that, bilateral procedures are feasible, and these procedures can be performed in any outpatient office with ultrasound availability, as emergency team backup is not necessary, making the procedure readily accessible. A cumulative benefit has been observed, as well. The effects of BHDCP with D5W as a stand-alone treatment for PTSD is under evaluated in a randomized trial compared treatment with D5W versus delayed treatment with early results promising. This study is designed as the next step in study quality through use of an injection control. The primary outcome is the short term and long-term effect of BHDCP with D5W versus NS on the Post Traumatic Stress Disorder Check List for Civilians (PCL-C), The primary hypotheses are tha cervical plexus hydrodissection with D5W will outperform NS for the primary measure, and that the PCL_C improvement will be equal to or greater than 15.3 (1.5 times the MCID of 10.2.). A study size of 100 participants is planned, based on power analysis.
Studietype
Registrering (Antatt)
Fase
- Fase 4
Kontakter og plasseringer
Studiekontakt
- Navn: Kenneth D Reeves, MD
- Telefonnummer: 9133621600
- E-post: DeanReevesmd@gmail.com
Studer Kontakt Backup
- Navn: Clare R Solso, RN
- Telefonnummer: 405 819 7777
- E-post: cereeves2002@hotmail.com
Studiesteder
-
-
Kentucky
-
Lexington, Kentucky, Forente stater, 40509
- Har ikke rekruttert ennå
- Wellward Medical
-
Ta kontakt med:
- Kenneth D Reeves, M.D.
- Telefonnummer: 913-362-1600
- E-post: DeanReevesMD@gmail.com
-
Ta kontakt med:
- Danesh Mazloomdoost, M.D.
- Telefonnummer: (443) 762-3505
- E-post: drd@wellwardmed.com
-
-
Oregon
-
Portland, Oregon, Forente stater, 97210
- Rekruttering
- NW Regen
-
Ta kontakt med:
- Kenneth D Reeves, M.D.
- Telefonnummer: 913-362-1600
- E-post: DeanReevesMD@gmail.com
-
Ta kontakt med:
- Ryan R Wood, N.D., D.C.
- Telefonnummer: 503-799-6115
- E-post: libby@nwregen.com
-
Portland, Oregon, Forente stater, 97210
- Rekruttering
- Paul Johnson, MD.
-
Ta kontakt med:
- Kenneth D Reeves, M.D.
- Telefonnummer: 913-362-1600
- E-post: DeanReevesMD@gmail.com
-
Ta kontakt med:
- Paul W Johnson, D.O.
- Telefonnummer: (412) 596-2606
- E-post: paulwjohnsonDO@yahoo.com
-
-
Wisconsin
-
Madison, Wisconsin, Forente stater, 53709
- Rekruttering
- Medical Procedures of Wisconsin
-
Ta kontakt med:
- Kenneth D Reeves, M.D.
- Telefonnummer: 913-362-1600
- E-post: DeanReevesMD@gmail.com
-
Ta kontakt med:
- Eric Phillippi, M.D.
- Telefonnummer: (262) 844-9123
- E-post: eric@medicalprocedures.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Inclusion Criteria:
- Not involved in another study of PTSD treatment
- Reliable transportation
- Comfortable with computers
- Tried 2 or more medications for treatment of PTSD symptoms
- Tried 2 or more non-medication treatments for PTSD symptom
- No known life-threatening illness
- Not taking daily narcotics
- Not having 3 or more alcoholic drinks on an average day
- No active suicidal plans
- No major surgery plans
- No major life stress that might interfere with completing study
- Symptoms for more than 1 year
- Not planning to move for next 18 months.
- Living within an hour of Portland, OR, Madison, WI, or Lexington, KY
- Wiling to provide 2 email and 2 phone contact methods
- Willing to answer questions on multiple occasions over the course of a year.
- Willing to be assigned to 3 months of usual care treatment
- No diagnosis of schizophrenia, Borderline Personality Disorder, or Bipolar Disorder.
- No severe needle phobia
- Chronic pain ≤ 5/10
- PCL-C score ≥ 50
Exclusion Criteria:
-
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Firemannsrom
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: D5W cervical plexus hydrodissection
10 ml D5W cervical plexus hydrodissection bilaterally at 0, 2, 4, and 8 weeks, and then by request from 13-52 weeks |
Injection under the investing fascia of the sternocleidomastoid muscle |
|
Aktiv komparator: Normal saline cervical plexus hydrodissection
10 mL normal saline cervical plexus hydrodissection bilaterally at 0, 2, 4, and 8 weeks, and then D5W by request from 13-52 weeks |
Injection under the investing fascia of the sternocleidomastoid muscle |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Post traumatic checklist for civilians
Tidsramme: 3 months
|
Minimum 17 Maximum 85 Higher scores mean worse outcome |
3 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Hospital anxiety and depression scale
Tidsramme: 3 months
|
Minimum 0 Maximum 42 Higher scores mean worse outcome |
3 months
|
|
EuroQol Visual Analog Scale (0-100 overall quality of life)
Tidsramme: 3 months
|
Minimum 0 Maximum 100 Higher scores mean better outcome |
3 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Kenneth D Reeves, M.D., Dr. Dean Reeves Clinic
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- BCPHD-D5WvsNSforPTSD
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
De-identified data are available from the first author upon request in writing and with a detailed use plan.
IPD-delingstidsramme
10 years
Tilgangskriterier for IPD-deling
Request in writing
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .